Cancer patients commonly experience pain, which often leads to a negative impact on patients’ functional status and quality of life. Management of cancer pain, including breakthrough and refractory pain, usually involves treatment with non-opioid and opioid analgesics, and must take into account the increased risk of adverse effects with these drugs.
This collection comprises a selection of recent high-quality full-text review articles from the Springer Nature portfolio that discuss cancer-related pain, including its clinical significance, methods for assessment and strategies for management. These are accompanied by additional selected full-text articles sourced from other prominent publishers.